Pictet Asset Management
ANIP icon

Pictet Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Pictet Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$284K Hold
3,436
– – ﹤0.01% 1797
2026
Q1 		$264K Buy
3,436
+638
+23% +$49.8K ﹤0.01% 1782
2025
Q4 		$221K Hold
2,798
– – ﹤0.01% 1870
2025
Q3 		$256K Buy
+2,798
New +$228K ﹤0.01% 1738

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pictet Asset Management's ANIP Position: Q2 2026 in Review

Pictet Asset Management held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 3,436 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #1797.

Pictet Asset Management first reported a position in ANIP in Q3 2025 and has held it in 4 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Pictet Asset Management held 3,436 shares of ANI Pharmaceuticals worth $284K as of Q2 2026.
  • Pictet Asset Management left its ANI Pharmaceuticals share count unchanged in Q2 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1797 holding.
  • Pictet Asset Management first reported a position in ANI Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.